Home » CHDI SELECTS EVOTEC AS STRATEGIC DRUG DISCOVERY PARTNER IN THE SEARCH FOR HUNTINGTON DISEASE TREATMENTS
CHDI SELECTS EVOTEC AS STRATEGIC DRUG DISCOVERY PARTNER IN THE SEARCH FOR HUNTINGTON DISEASE TREATMENTS
Evotec AG announced that CHDI, Inc., a not-for profit organisation pursuing a biotech approach to finding therapies for Huntington Disease, has chosen Evotec as a strategic partner for helping them advance its drug discovery programmes. Pipeline Review (http://www.pipelinereview.com/joomla/content/view/5804/117/)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May